Here’s what you need to know.
1. Neovasc is an advanced biological tissue business.
2. Boston Scientific is acquiring certain manufacturing assets and capabilities, and will integrate them into its structural heart business for use in Boston Scientific’s Lotus Valve System.
3. As part of the deal, Boston Scientific is taking a 15 percent ownership in Neovasc.
More articles on gastroenterology/endoscopy:
FDA awards 510(k) clearance to DiLumen: 4 things to know
GI leader to know: Dr. Sidney Neimark of the Digestive Center of the Palm Beaches
IBD monitoring index may pave the way for GI mobile health: 3 study insights
